Clinical trial results suggest that Wegovy® 7.2mg may help some patients achieve greater weight loss compared with lower doses.
In the STEP UP clinical trial published in January 2025, adults with a BMI of 27 or above using Wegovy® (semaglutide) 7.2mg achieved an average weight loss of 20.7% of their body weight after 72 weeks (approximately 1 year and 5 months) when looking at patients who remained on treatment.*
Everyone responds differently, and weight loss results cannot be guaranteed. Your results will depend on factors including your starting weight, lifestyle changes, medication tolerance and how consistently treatment is followed.
At Lotus Weight Loss Clinic, Wegovy® treatment is combined with ongoing clinical support to help patients achieve safe and sustainable results.
*Based on STEP UP trial data. Evidence in people with lower BMIs is limited, and individual outcomes vary.